Medical - delivering value through complex product development
With more than 25 years of experience working with clients as an end-end product development partner, Sagentia is well placed to help medical device companies respond to the industry’s challenges. We focus on delivering innovative medical products in four key areas: point of care diagnostics, surgical devices, and patient care.
The global healthcare sector is facing continued pressure to demonstrate greater health effectiveness and improved cost efficiency of all new products and procedures. With the combination of financial cutbacks, regulatory and reimbursement changes, evolving user characteristics and the transition towards connected
health, medical device manufacturers need to deliver value based innovation for their products and services to stay ahead.
At Sagentia we work across the boundaries of the patient care continuum, identifying and developing innovative surgical, diagnostic and patient care devices and systems. With a year track record of
more than 27 years in the industry, we know the importance of combining science, technology, engineering and user focused design to solve difficult R&D challenges and we are well placed to help medical device companies respond to the industry’s challenges.
We work with clients from front end innovation and market needs analysis, through detailed design and product development, to transfer to manufacture. Many of our medical device developments also include complex software development, which is one of our core capabilities.
We’ve delivered technology innovation and value to a wide range of clients including: Johnson & Johnson, AstraZeneca, Smith & Nephew, Alere, St Jude Medical, T2 Biosystems, Titan and Photocure.
Sagentia co-developed the transmitter, from initial specification through to transfer to manufacture, providing expertise in the selection of low-cost products, consumer product design and electronics and software development.
Sagentia developed the system and its high volume consumable from initial thermal concept and modelling through to transfer to manufacture. In order to meet clinical trial deadlines Sagentia supplemented its standard transfer to production activities with the manufacture and build of the first batch of systems. The system has successfully completed clinical trials and was showcased at Medica in November 2009. It is now being commercialised in countries including India, Brazil and Russia.
Sagentia was involved throughout the design and development of the device for Prosurgics, a venture funded medical device company. Now with FDA and CE approval, the device has provided a range of benefits to surgeons including better image visualisation and reduced camera shake. It is also contributing to improved surgical efficiency through reduced operating times.
Sagentia has more than 25 years experience working with clients as an end-to-end product development partner.